The government has reopened the PLI scheme for bulk drugs, inviting fresh applications for meropenem and ritonavir to boost domestic API production. The move follows industry demand and aims to reduce ...
The AI firm details how it is identifying large‑scale model‑copying attempts and the countermeasures it is rolling out.
14don MSN
Explained: What is India’s Sarvam AI model that Google CEO Sundar Pichai is quite impressed with
Google CEO Sundar Pichai lauded Sarvam AI for its advancements in local AI models tailored for Indian languages and contexts. The startup's AI model reportedly outperforms major players like Google's ...
With a substantial manufacturing base already locked down in China, CRDMO BioDuro is taking a short jaunt down to Taiwan for its latest drug ingredients production play. | BioDuro, headquartered in ...
Finding out how microbes make compounds containing the diazo chemical group could help researchers to synthesize useful ...
BioDuro, a CRDMO, has established a joint venture with Cenra API Solutions, a pharmaceutical chemical manufacturer in Taiwan.
AbbVie’s $100 billion splurge on domestic manufacturing and R&D is continuing to come into focus, this time with a $380 million investment in two new active pharmaceutical ingredient manufactur | The ...
Part of AbbVie’s vow to invest $100 billion in the U.S. over the next decade, the two Illinois facilities will make active ingredients for next-generation neuroscience and obesity drugs when they ...
LONDON, UNITED KINGDOM, UNITED KINGDOM, January 20, 2026 /EINPresswire.com/ — Strategic Revenue Insights Inc. The Catalysts for Chemical Manufacturing Market is ...
Market valued at $27.64B in 2024, projected 3.94% CAGR growth driven by petroleum refining, green chemistry, biocatalysts, and environmental catalyst demand. Catalysts enable chemical manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results